Earnings Outlook For 10x Genomics
Portfolio Pulse from Benzinga Insights
10x Genomics (NASDAQ:TXG) is set to release its latest quarterly earnings report on August 3, 2023. Analysts estimate an EPS of $-0.39. The company's past performance shows a pattern of share price increase following earnings reports, even when EPS estimates were missed. The stock is currently trading at $62.25 and has seen a 39.31% increase over the last 52-week period.
August 04, 2023 | 11:54 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
10x Genomics is expected to report an EPS of $-0.39 in its upcoming earnings. The company's stock has historically increased following earnings reports, suggesting potential positive short-term impact.
10x Genomics has a history of its stock price increasing following earnings reports, even when it misses EPS estimates. This suggests that investors may be more focused on the company's guidance and future growth prospects. Given this pattern, the upcoming earnings report could have a positive short-term impact on the company's stock.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100